“Patient-Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis in Real-World Settings: PROAK Study Protocol”. 2022. SKIN The Journal of Cutaneous Medicine 6 (2): s19. https://doi.org/10.25251/skin.6.supp.19.